Skip to Main Content

Paper Details

AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance.
1
2022
16q12, AKTIP, CAND1, Cullin-associated and neddylation-dissociated protein 1, E3 ubiquitin, ER, ER protein, ER-, ER-negative, breast cancer cells, ER-positive breast cancer, ER-positive patient-derived organoids, JAK2, RING, STAT3, breast cancer, cullin, cullin 2, estrogen, estrogen receptor alpha, luminal breast cancer, patient, patients, positive breast cancer, tumors
Author NameAffiliation
Yiling LuUT MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2